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Schizophrenia is a severe mental illness that represents a significant public 
health burden.  No treatments are FDA approved for negative symptoms of 
schizophrenia, primarily because there is no valid, reliable measure for n gative 
symptoms.  A new negative symptom measure, the Negative Symptom Rating Scale 
(NSRS), is in the initial phases of validation.  The current study assesses the 
convergent validity of the scale by examining the relationship between th NSRS and 
expressed facial affect.  The study also sought to clarify the relationship between 
expressed facial affect and functioning.  The results revealed a significant relationship 
between expressed facial affect and the NSRS subscale of blunted affect, as predicted.  
However, there was not a significant relationship between expressed facial a fect and 
functioning.  These results provide initial evidence for the convergent validity of the 
  
scale.  Currently, there is an ongoing research study to further assess the reliability 











































AN INITIAL ASESSMENT OF THE CONVERGENT VALIDITY OF THE 
NEGATIVE SYMPTOM RATING SCALE: THE RELATIONSHIP BETWEEN 
BEHAVIORAL CODINGS OF EXPRESSED FACIAL AFFECT AND CLINICAL 













Thesis submitted to the Faculty of the Graduate School of the  
University of Maryland, College Park, in partial fulfillment 
of the requirements for the degree of 













Professor Jack J. Blanchard, Chair 
Professor Barry Smith 






















© Copyright by 



















The author would like to thank Jack Blanchard and Shannon Couture for their 
guidance on this project.  Further, the author would like to thank Melanie Bennett, 
Courtney Forbes, Amy Wilson, Katiah Llerena and Stephanie Lin for their ass stance 




Table of Contents 
 
 
Acknowledgements ....................................................................................................... ii 
Table of Contents ......................................................................................................... iii 
List of Tables ................................................................................................................ v 
List of Figures .............................................................................................................. vi 
Chapter 1: Introduction ................................................................................................. 1 
Background ............................................................................................................... 1 
NIMH Negative Symptom Consensus Conference .............................................. 3 
Measurement of Negative Symptoms ....................................................................... 4 
Brief Psychiatric Rating Scale .............................................................................. 4 
Scale for the Assessment of Negative Symptoms................................................. 5 
Positive and Negative Symptom Scale ................................................................. 5 
Limitations of Current Measures .......................................................................... 6 
The Negative Symptom Rating Scale ....................................................................... 7 
Subscales of the Negative Symptom Rating Scale ............................................... 9 
Validation of the Negative Symptom Rating Scale ................................................ 12 
Blunted Affect ..................................................................................................... 14 
Negative Symptoms and Emotion ...................................................................... 15 
Expressed Facial Affect and Social Functioning ................................................ 17 
Chapter 2: Rationale ................................................................................................... 20 
Hypotheses .............................................................................................................. 21 
Chapter 3: Method ...................................................................................................... 22 
Design and Methodology ........................................................................................ 22 
Participant Recruitment and Inclusion/Exclusion Criteria ................................. 22 
Procedure ............................................................................................................ 23 
Measures ................................................................................................................. 25 
Symptom Measures ............................................................................................. 25 
Functioning Measure .......................................................................................... 27 
Behavioral Ratings of Expressed Facial Affect .................................................. 28 
Chapter 4: Results ....................................................................................................... 30 
Sample Characteristics ............................................................................................ 30 
Analyses .................................................................................................................. 30 
Procedures to Address Missing Data .................................................................. 30 
FACES Variables ................................................................................................ 31 
Correlations Among FACES Variables .............................................................. 32 
Correlations Between FACES Variables and Negative Symptom Ratings ........ 33 
Correlations between FACES ratings and Psychotic and Depressive Symptoms
............................................................................................................................. 35 
Correlations Between FACES Ratings and Functioning .................................... 35 
Chapter 5:  Discussion ................................................................................................ 36 
Limitations .............................................................................................................. 42 
Future Directions and Conclusions ......................................................................... 45 




Appendix A: Negative Symptom Rating Scale ...................................................... 48 
Appendix B: Brief Psychiatric Rating Scale ........................................................... 55 
Appendix C: Calgary Depression Scale for Schizophrenia .................................... 67 
Appendix D: Social Functioning Scale ................................................................... 70 
Appendix E: Facial Affect Coding System Manual ............................................... 75 
Appendix F: ............................................................................................................ 85 
Facial Affect Coding System Summary Sheet........................................................ 85 














List of Tables 
 
1.  Demographic Characteristics for the Patient Sample…………………………...87 
2.  Intra-class Correlations (ICC) for FACES Variables…………………………...88 
3. Correlations Between Individual FACES Variables…………………………….89 
4. Correlations Between NSRS Subscales and FACES Variables……………90 
5. Correlations between FACES Subscales and Psychotic and Depressive 
Symptomatology………………………………………………………………...91 



































List of Figures 
 




Chapter 1: Introduction 
Background  
Schizophrenia is a severe mental illness that affects approximately one percent 
of the general population (Jablensky, 2000).  According to the DSM-IV (American 
Psychiatric Association, 2000), two or more of the five hallmark symptoms, including 
delusions, hallucinations, disorganized speech, grossly disorganized or catatonic 
behavior, and negative symptoms (i.e., affective flattening, alogia, or avolition), must 
be present for a significant portion of time over a period of one month to receive a 
diagnosis of schizophrenia.  Additionally, there must be continuous signs of 
disturbance for at least six months, and the individual must exhibit social or 
occupational dysfunction.  Given that an individual only needs to meet two of the five 
symptom criteria, it is possible for individuals to share the same diagnosis of 
schizophrenia but exhibit vastly different symptom presentations (Earnst & Kring, 
1997).  This phenotypic heterogeneity of schizophrenia symptoms has long been 
acknowledged in the literature, and has often been associated with discussions 
regarding various methods for subtyping or otherwise categorizing aspects of the 
illness (Sass, 1989). One such categorization is the positive-negative dichotomy 
(Andreasen, 1982).  “Positive” refers to overtly psychotic symptoms, such as 
delusions and hallucinations, and “negative,” refers to symptoms characterized by 
loss of functioning, such as reduced emotional expression (blunted affect) and 




The creation of dichotomies, such as positive-negative, acute-chronic, and 
accessory-fundamental, provides both clinician and researchers with ways in which to 
simplify the complexities of schizophrenic illness (Sass, 1989).  In the last twen y-
five years, much research has been conducted regarding the positive-negative 
symptom distinction resulting in well-replicated findings that demonstrate a 
relationship between negative symptoms and both poor premorbid functioning and 
various indicators of poor prognosis (Earnst & Kring, 1997) including impaired social 
functioning (Schuldberg, Quinlan, & Glazer, 1999), quality of life (Addington & 
Addington, 2000; Ho, Nopoulos, Flaum, Arndt, & Andreasen, 1998; Hofer, 
Baumgartner, Edlinger, Humer, Kemmler, Rettenbacher, et al., 2005; Norman, Malla, 
Cortese, Cheng, Diaz, McIntosh et al., 1999; Norman, Malla, McLean, Panth, 
Voruganti, Cortese et al., 2000), social problem solving skills (Addington & 
Addington, 2000; Patterson, Moscana, McKibbin, Davidson, & Jeste, 2001), 
residential independence (Dickerson, Ringel, & Parente, 1999; Hofer, Baumgartner, 
Edinger, Humer, Kemmler, Rettenbacher, et al. 2005; Siegal, Irani, & Brensing r, 
2006), and occupational functioning (Breier, Schreiber, Dyer, & Pickar, 1991; Evans, 
Meyers, Kim, Lysaker, Gibson, et al., 2004; Fenton & McGlashan, 1991; Hoffman, 
Kupper, Zbinden, & Hirsbrunner, 2003; Lysacker & Bell, 1995; McGurk & Meltzer, 
2000; Schuldberg et al., 1999).  Additionally, research has demonstrated that negative 
symptoms are predictive of a particularly poor course of the disorder including partial 
or no remissions during the first years of illness and a progressive course ultimately 
leading to permanent disability (Fenton & McGlashan, 1991). While negative 




significant improvement in negative symptoms (Buckley & Stahl, 2007), and no drug 
has received Food and Drug Administration (FDA) approval for the treatment of 
negative symptoms (Kirkpatrick, Fenton, Carpenter, & Marder, 2006).   
NIMH Negative Symptom Consensus Conference 
As negative symptoms have been shown to be related to significant deficits in 
functioning and have proven difficult to treat, the National Institute of Mental He th 
(NIMH) sponsored a consensus conference to identify research priorities for 
stimulating the development of novel treatments for negative symptoms (Kirkpatric  
et al., 2006).  The Measurement and Treatment Research to Improve Cognition in 
Schizophrenia (MATRICS) project was organized, in collaboration with negative 
symptoms researchers, to specifically address the challenge of eff ctiv ly treating the 
negative symptoms domain (Kirkpatrick et al., 2006).  This NIMH-MATRICS 
Consensus Development Conference on Negative Symptoms concluded the 
following: (1) negative symptoms constitute a distinct therapeutic indication rea, (2) 
negative symptoms and cognitive impairments represent separate domains, and (3) 
negative symptoms are an unmet therapeutic need for a large proportion of those 
diagnosed with schizophrenia.  In addition, it was determined that a significant barrier
to progress in the treatment of negative symptoms is the lack of an adequate measure
for assessment because the limitations of existing negative symptom measures are 
serious and substantial.   As such, a key recommendation resulting from the 
conference was that a new negative symptom assessment instrument be developed to 




(Kirkpatrick et al., 2006).  Measurement issues in commonly used negative symptom 
assessment instruments will be reviewed below. 
Measurement of Negative Symptoms 
The following is a brief overview of the development, initial validation and 
limitations of three of the most widely used instruments measuring negative 
symptoms.  Although several negative symptom scales are available, the NIMH 
workgroup concluded that each is problematic.  There is no consensus regarding 
which symptoms make up the negative symptom construct leading to inconsistencies 
in definitions and item content across the available measures (Earnst & Kring, 1997; 
McGlashan & Fenton, 1992).  Such inconsistencies in measurement likely account for 
the variability of results in the research literature and hinder the interpre ation of 
findings across studies (Earnst & Kring, 1997).   
Brief Psychiatric Rating Scale 
One of the most widely used general psychiatric scales is the Brief Psychiatric 
Rating Scale (BPRS; Overall & Gorham, 1962), which consists of items pertaining to 
affect, positive symptoms, negative symptoms, resistance and activation.  While this 
measure does provide some method in which to assess negative symptoms, it is 
greatly limited given that this scale only includes three negative items (i.e., blunted 
affect, emotional withdrawal, motor retardation).  Other negative symptoms such a  
alogia (poverty of speech), anhedonia (reduced ability to experience pleasure) nd 





Scale for the Assessment of Negative Symptoms 
The first measure designed specifically to assess the negative symptom 
domain is the Scale for the Assessment of Negative Symptoms (SANS; Andreasen, 
1982).  This scale rates the severity of five negative symptoms including alogia 
(poverty of speech), affective flattening (reduced range of emotions), avolition-apathy 
(reduced motivation), anhedonia-asociality (reduced ability to experience pleasure, 
reduced social drive) and attentional impairment.  The final item for each symptom 
domain is a global rating of severity.  Results of the initial evaluation of the SANS 
demonstrated high levels of inter-rater reliability for each item as well as good 
internal consistency (alpha = .885) as determined using the composite score 
(Andreasen, 1982).  Negative symptom domains on the SANS have been shown to be 
highly correlated with each other (Peralta, Cuesta & de Leon, 1995).  However, 
analyses revealed that inappropriate affect exhibited a low correlation wi h affective 
flattening raising questions regarding its appropriateness as a measure of negative 
symptoms.   
Positive and Negative Symptom Scale 
In an attempt to improve upon both the BPRS and the SANS, Kay, Fizbein, & 
Opler and (1987) developed the Positive and Negative Syndrome Scale (PANSS; Kay 
et al., 1987).  The PANSS utilizes all 18 items from the BPRS, as well as 12 items 
from the Psychopathology Rating Scale (Singh & Kay, 1975), to assess positive 
symptoms, negative symptoms and general psychopathology.  Items included in this 
scale were chosen based on their consistency with theoretical concepts, classification 




medication side effects) and an attempt to sample from diverse domains of 
functioning (Kay, Opler, & Lindenmayer, 1989).  Initial evaluation of the PANSS 
demonstrated high levels of inter-rater, split-half, and test-retest reliability as well as 
good internal consistency (Kay et al., 1989).  Additionally, the negative symptoms 
scale of the PANSS was found to be significantly correlated (r = .77) with the SANS 
providing evidence of construct validity.  Negative symptom domains on the PANSS 
have been found to be highly correlated with each other (Peralta et al., 1995).  With 
regards to the relationship of the negative scale with external validators, negative 
symptoms exhibited an association with slower motor activity, affective deficits, 
impoverished thinking, lower levels of education, cognitive dysfunction and a family 
history of psychosis (Kay et al., 1989).    
Limitations of Current Measures 
 
With regards to item content, both the SANS and PANSS exhibit various 
limitations.  For example, the SANS items tapping inappropriate affect, blocking, and 
attentional impairment have been questioned with regard to their fit within the 
negative symptom construct (Breier et al., 1991).  These item issues have been noted 
by various investigators (Kay, 1990; Kay et al., 1989; Walker, Harvey, & Perlman, 
1988) including the developer of the SANS (Andreasen, 1982).  However, the SANS 
has not been updated to remedy these concerns.  Also, both the SANS and PANSS 
include cognitive functioning content that is conceptually distinct from current viws 
of negative symptoms. As mentioned above, the SANS includes ratings of attention, 
and the PANSS additionally rates abstract thinking and stereotyped thinking. Factor 




negative symptom ratings (Sayers, Curran, & Mueser, 1994; White, Harvey, Opler, & 
Lindenmayer, 1997).  Therefore, the symptom ratings included in these scales do not 
reflect the core deficits of the negative symptom domain. Additionally, the inclus on 
of cognitive variables may result in inflated estimates of covariation between negative 
symptoms and neuropsychological impairment (Harvey, Koren, Reichenberg, & 
Bowie, 2006).   Furthermore, a serious limitation of the PANSS is the low number of 
items used to assess the construct with seven single items each assessing an entire 
subdomain of negative symptoms.  This is despite the fact that single item scales 
typically demonstrate quite poor psychometric properties.  Moreover, neither the 
SANS nor the PANSS delineate behavior from affective states, desire, or 
environmental factors that could limit behavior.  For example, a person with 
schizophrenia may not engage with others socially, because they cannot afford 
transportation.  Thus, the SANS and the PANSS do not take into account other factors 
that could influence behavior and be mistaken for negative symptoms.  Additionally, 
this problem may be the cause of the high correlation between these measures and 
functional outcome measures, because they are so behaviorally based. Thus, these 
measures may reflect functional outcomes rather than actual negative 
symptomatology.  There are clearly a number of significant limitations associated 
with the current instruments used to assess negative symptoms.   
 
 
The Negative Symptom Rating Scale 
In response to the need for an improved measure that addresses concerns with 




Rating Scale (NSRS).  The NSRS was designed to assess domains of negative 
symptoms identified and agreed upon by the consensus group, namely blunted affect 
(decreases in outward expression of emotion), alogia (decrease in amount of speech), 
asociality (decreased interest and participation in social relationships), anhedonia 
(decrease in experiencing pleasure) and avolition (decrease in goal-directed activity) 
(Kirkpatrick et al., 2006).   
While the domains covered by the NSRS closely approximate those assessed 
by the SANS, the item content of the NSRS differs in focus by specifically tapping 
experiential deficits in addition to performance or achievement deficits.  For example, 
within the anhedonia domain the NSRS items assess deficits in hedonic capacity 
rather than social performance as is assessed by other negative symptom measures 
(e.g., SANS).  Additionally, the NSRS assessment of asociality attempts to reduce the 
conflation of successful social engagement with the experience of interest in social 
activity that is present in previous measures.  This differentiation is important, 
because often those with schizophrenia may live in impoverished environments, 
which, in turn, influences their behavior.  Thus, those with schizophrenia may have 
interest in being social or being employed, but environmental factors, such as lack of
transportation or disability status, may result in a lack of social behavior or a lack of 
employment. Therefore, it is important to distinguish between interest and actual 
behavior in order to properly assess for negative symptoms.  With that, the NSRS 
requires that both diminished interest and social isolation co-occur to obtain high 
ratings within this domain.  The measure, which includes 25 items covering five 




Figure 1.  Subscales of the Negative Symptom Rating Scale 
I. Anhedonia  
a. Expected or Anticipated Pleasure (social, physical, 
recreational/vocational) 




b. Romantic Relationships 
c. Friends 
III. Avolition 
a. Social Interactions 
b. Work/Vocational/School Activities 
c. Recreation/Hobbies/Pastimes 
d. Self-Care 
IV. Blunted Affect 
a. Facial Expression 
b. Vocal Expression 
c. Expressive Gestures 
d. Eye Contact 
e. Spontaneous Movements 
V. Alogia 
a. Quantity of Speech 
b. Spontaneous Elaboration 
 
Subscales of the Negative Symptom Rating Scale 
The anhedonia subscale measures both expected or anticipated pleasure from 
future activity (i.e., anticipatory pleasure) as well as pleasure during an activity (i.e., 
consummatory pleasure) following the recommendation of Gard and colleagues 
(2007).  Ratings of intensity are made for anticipatory pleasure, and ratings of 
intensity and frequency are made for consummatory pleasure.  The domains covered 
in these ratings are broadened beyond those addressed in previous measures and 




Additionally, the NSRS allows for a differentiation between the experiential and 
performance deficits associated with anhedonia as described above. 
 The asociality subscale assesses internal experiences regarding the de re  to 
which close social bonds are valued and desired as well as the observable behavior of 
actually engaging in social interactions.  Again, the number of domains assessed was 
broadened to include family relationships, romantic relationships and friendships.  
Reports on both internal and observable aspects of asociality allow the interviewer to 
determine whether decreased social activity results from true asociality or from other 
sources (e.g., decreased social skills, social anxiety, paranoid beliefs). Ratings for the 
asociality subscale do not reflect pleasure derived from social activities (which is 
rated under anhedonia) or the extent to which the subject initiates or is motivated to 
seek out social activity (which is rated under avolition). 
The avolition subscale assesses four areas including social activity, 
work/vocational/school, recreation, and self-care.  Again, both overt behavior and 
internal experience are considered in making the ratings to determine the presence or 
absence of other sources leading to the failure to initiate or persist in activ ty (e.g., 
decreased opportunity, paranoid beliefs) that are not a result of negative symptoms.  
The assessment of both behavior and motivation is critical as a failure to initiate and 
persist in activity may be due to several sources other than avolition, including 
decreased opportunity or paranoid beliefs. A patient may have a decrease in goal-
directed behavior but still receive a relatively low rating on avolition if the individual 
has a desire to engage in such behavior. Conversely, patients who report participating 




program) but are not motivated to do so or do not initiate the activities themselves 
may receive a higher score on this scale than those who are less active but initiate 
activities on their own. 
The blunted affect subscale score is obtained via interview prompts that are 
designed to elicit emotion (tapping both positive and negative emotional experiences) 
rather than based exclusively on observations of expressivity within the clinical 
interview as was done with prior measures.  Such probing is expected to yield more 
valid and reliable ratings of individual differences in blunted expression.  The 
domains assessed within this subscale of the NSRS include facial expression, vocal 
expression, expressive gestures, eye contact and spontaneous movements.   
Ratings for the alogia subscale are based on the responses given throughout 
the interview with assessments of quantity of speech and amount of spontaneous 
elaboration.  Quantity ratings are restricted to the speech produced in responding t 
the NSRS interview. Other speech abnormalities, such as disorganization, neologisms 
or psychotic content are not rated here.   For the spontaneous elaboration item, 
interviewers rate the amount of information given beyond what is strictly necessary in 
order to respond to the NSRS questions. Whether or not the responses are appropriate 
is not considered. 
 With regards to the overall organization of the NSRS, the instrument is 
formatted as a semi-structured interview with numerous prompts and queries 
provided for each item.  Additionally, effort was made to provide clear anchors for 
making ratings, often including exemplars of answers that would fall under a 




Validation of the Negative Symptom Rating Scale 
The anhedonia subscale measures both expected or anticipated pleasure from 
future activity (i.e., anticipatory pleasure) as well as pleasure during an activity (i.e., 
consummatory pleasure) following the recommendation of Gard and colleagues 
(2007).  Ratings of intensity are made for anticipatory pleasure, and ratings of 
intensity and frequency are made for consummatory pleasure.  The domains covered 
in these ratings are broadened beyond those addressed in previous measures and 
include social activities, physical sensations and recreational/vocational activities.  
Additionally, the NSRS allows for a differentiation between the experiential and 
performance deficits associated with anhedonia as described above. 
 The asociality subscale assesses internal experiences regarding the de re  to 
which close social bonds are valued and desired as well as the observable behavior of 
actually engaging in social interactions.  Again, the number of domains assessed was 
broadened to include family relationships, romantic relationships and friendships.  
Reports on both internal and observable aspects of asociality allow the interviewer to 
determine whether decreased social activity results from true asociality or from other 
sources (e.g., decreased social skills, social anxiety, paranoid beliefs). Ratings for the 
asociality subscale do not reflect pleasure derived from social activities (which is 
rated under anhedonia) or the extent to which the subject initiates or is motivated to 
seek out social activity (which is rated under avolition). 
The avolition subscale assesses four areas including social activity, 
work/vocational/school, recreation, and self-care.  Again, both overt behavior and 




absence of other sources leading to the failure to initiate or persist in activ ty (e.g., 
decreased opportunity, paranoid beliefs) that are not a result of negative symptoms.  
The assessment of both behavior and motivation is critical as a failure to initiate and 
persist in activity may be due to several sources other than avolition, including 
decreased opportunity or paranoid beliefs. A patient may have a decrease in goal-
directed behavior but still receive a relatively low rating on avolition if the individual 
has a desire to engage in such behavior. Conversely, patients who report participating 
in many activities because they are required to (e.g., requirements of a day treatment 
program) but are not motivated to do so or do not initiate the activities themselves 
may receive a higher score on this scale than those who are less active but initiate 
activities on their own. 
The blunted affect subscale score is obtained via interview prompts that are 
designed to elicit emotion (tapping both positive and negative emotional experiences) 
rather than based exclusively on observations of expressivity within the clinical 
interview as was done with prior measures.  Such probing is expected to yield more 
valid and reliable ratings of individual differences in blunted expression.  The 
domains assessed within this subscale of the NSRS include facial expression, vocal 
expression, expressive gestures, eye contact and spontaneous movements.   
Ratings for the alogia subscale are based on the responses given throughout 
the interview with assessments of quantity of speech and amount of spontaneous 
elaboration.  Quantity ratings are restricted to the speech produced in responding t 
the NSRS interview. Other speech abnormalities, such as disorganization, neologisms 




interviewers rate the amount of information given beyond what is strictly necessary in 
order to respond to the NSRS questions. Whether or not the responses are appropriate 
is not considered. 
 With regards to the overall organization of the NSRS, the instrument is 
formatted as a semi-structured interview with numerous prompts and queries 
provided for each item.  Additionally, effort was made to provide clear anchors for 
making ratings, often including exemplars of answers that would fall under a 
particular score (e.g., Mild Pleasure – “nice,” “fine,” "somewhat pleasurable"). 
Blunted Affect 
Blunted affect is a key component of the negative symptom construct.  In 
terms of measurement of negative symptoms, blunted affect has been a fundamental 
element of every negative symptom instrument (i.e., BPRS; Overall & Gorham, 1962; 
SANS; Andreasen, 1982; PANSS; Kay et al., 1987).  Additionally, blunted affect was 
included in the MATRICS consensus statement as a primary domain within the 
negative symptom concept (Kirkpatrick et al., 2006).   Thus, blunted affect has 
historically been a key component in both the construct and measurement of negative 
symptoms (Kirkpatrick et al., 2006).  
Blunted affect is also reliably associated with other negative symptoms, as 
well as emerging as an independent factor in studies examining the structure of 
negative symptoms.  Specifically, analyses of the SANS and the PANSS have 
revealed that blunted affect is correlated with asociality (Kelley, van Kammen, & 
Allen, 1999; Peralta & Cuesta, 1999), anhedonia (Kelley et al., 1999; Peralta & 




analyses of the negative symptom construct, diminished expression and blunted affect 
consistently emerge as a unique factor (Blanchard & Cohen, 2006; Keefe, Harvey, 
Lenzenweger, Davidson, Apter, Schmeidler, et al., 1992; Kelley et al., 1999; Peralta 
& Cuesta, 1999).  
 The construct of blunted affect, as defined by the NSRS, comprises deficits 
several different behaviors including facial affect, vocal expression, expressive 
gestures, eye contact, and spontaneous movements.  Thus, diminished emotional 
expression through facial affect and vocal expression are two components of this 
construct.  Diminished emotional expression has been reliably measured in many 
laboratory studies.  Literature on laboratory studies of diminished emotional 
expression is reviewed below.   
Negative Symptoms and Emotion 
Laboratory studies have provided evidence for reduced emotional expressivity in 
response to evocative stimuli in those with schizophrenia (Berenbaum & Oltmanns, 
1992; Dworkin et al., 1996; Kring, Kerr et al., 1993; Kring & Neale, 1996; Wolf et 
al., 2006). In these studies, researchers measure emotional experience and 
expressivity via expressed facial affect, self-report, clinican-rated interviews and 
electrodermal activity. In comparison to nonclinical control groups, those with 
schizophrenia express less facial emotion in response to a wide range of situations 
employing various types of stimuli intended to produce emotion (Berenbaum, & 
Oltmanns, 1992; Dworkin, Clark, Amador, & Gorman, 1996; Kring et al., 1993; 
Kring & Neale, 1996; Wolf, Mass, Kiefer, Wiedemann, & Naber, 2006) and during a 




Alpert, & Welkowitz, 1998).  Of note, this reduced emotional expressivity is also 
apparent while those with schizophrenia are participating in social interactions 
(Aghevli, Blanchard, & Horan, 2003).   
Additional studies have examined whether individuals with schizophrenia can 
intentionally change facial displays of emotion.  One study examined the relationship 
between emotional expression, experienced emotion and negative symptoms in 
schizophrenia (Henry, Rendell, Green, McDonald, & O'Donnell, 2008).  Participants 
with schizophrenia and a nonclinical comparison group viewed comedic film clips 
while employing emotion regulation strategies.  Specifically, participants were asked 
to “amplify” their facial expressions of emotion (by displaying more facial affect) or 
to “suppress,” or reduce, their emotional expressivity.  Compared to controls, those 
with schizophrenia were found to have deficits in amplifying their emotions, but not 
in suppressing emotionally expressive behavior (Henry et al., 2008).  Interestingly, 
these deficits in the ability to amplify emotional expressions were significa tly 
correlated with total negative symptomatology. More specifically, a deficit in the 
ability to amplify expressed emotions was correlated with emotional blunting (Henry 
et al., 2008).  
In summary, blunted affect is a key component of the negative symptom 
construct and can be reliably measured via facial displays of affect.  Correlating 
behavioral coding of expressed facial affect with the NSRS will move beyond 
standard clinical ratings of blunted affect in order to determine whether the NSRS
correlates with independent behavioral ratings of facial affect providing co vergent 




relationship between expressivity and negative symptoms can be explored.  Since 
negative symptoms are highly correlated with each other, behavioral ratings of facial 
affect should also correlate with other negative symptoms (i.e., anhedonia, avolition, 
alogia and asociality).  In a pilot study employing the NSRS, negative symptoms 
were independent of psychotic and depressive symptoms (Forbes et al., manuscript in 
preparation).  Since FACES ratings are expected to be correlated with negative 
symptoms, it is also expected that they will be independent of psychotic and 
depressive symptoms.  Additionally, the relationship between expressed facial a fect 
and functioning will be examined. 
 
Expressed Facial Affect and Social Functioning 
A secondary aim of the current study is to examine the relationship among 
expressed facial affect and functioning.  Poor functioning, which includes social 
functioning, work functioning and independent living skills, among other domains, is 
a hallmark of schizophrenia.  Deficits in social functioning are apparent in both the 
premorbid phases of schizophrenia and throughout the course of the illness 
(Addington, Penn, Woods, Addington & Perkins, 2008; Cannon, Jones, Gilvarry, 
Rifkin, McKenzie, Foerster, & Murray, 1997).  Individuals with schizophrenia often 
identify problems in functioning as being as distressing as symptom domains such as 
hallucinations and delusions (Bengtsson-Tops & Hansson, 1999).  Clearly, enhancing 
our understanding of functioning deficits in schizophrenia would have significant 
benefit. However, specific contributions to these deficits are unclear.  In the following 





One factor, which may contribute to functioning in individuals diagnosed with 
schizophrenia, is a deficit in emotional expression.  An essential element of effectiv  
social interactions is the expression of emotion, and the inability to express emotion 
effectively can cause the deterioration of the relationship (Keltner & K ing, 1998).  
Blunted affect, in particular, is associated with deficits in the expression of em tion 
and may contribute to poor social functioning in schizophrenia.  Within schizophrenic 
patient populations, deficits in facial emotional expression are noticeable during
social interactions (Aghevli et al., 2003).  Additionally, as discussed previously, thi 
population is unable to amplify emotional facial expressions (Henry et al., 2008).  
Arguably, the ability to intensify one’s display of facial affect can be important in the 
communication of social interest to others.  Additionally, other social skills, such as 
interest in one’s communication partner, are considered to be essential in social 
communication (Kopelowicz, Liberman & Zarate, 2006).  Those with schizophrenia 
have noticeable deficits in these basic social skills (Kopelowicz et al., 2006).  Thus,
while participating in social interactions, those deeply affected by the negative 
symptoms of schizophrenia are likely not giving appropriate social cues, such as 
smiling, and making proper eye contact, which, in turn, causes them to be less 
socially effective (Blanchard & Panzarella, 1998).  However, the precise relationship 
between expressed facial affect and functioning remains unclear.    
In summary, schizophrenia is associated with deficits in several domains of 
functioning.  Expressed facial affect plays a major role in social relationships.  




functioning remains unknown.  One way to examine this relationship is to relate 








Chapter 2: Rationale 
Negative symptoms in schizophrenia are a major determinant of the social and 
occupational impairments that characterize the disorder, a significant sourceof 
distress for caregivers, and predictor of poor long-term outcome. Despite compelling 
evidence for the clinical relevance of negative symptoms, this domain of the illness
remains inadequately addressed by current pharmacotherapy and psychotherapy.  As 
reviewed above, there is consensus among academic researchers, industry researchers 
and the FDA that improved measurement is essential for the field to progress in the 
development of effective treatments for negative symptoms in schizophrenia 
(Kirkpatrick et al., 2006), which led to the collaborative effort of creating the NSRS.   
Although the NSRS is the result of an ongoing collaborative NIMH-led effort 
over the last two years, the measure clearly requires empirical scrutiny before it can 
be adopted for clinical trials and research. Despite what are seen as important 
advancements to the assessment of negative symptoms, it is necessary to ensure that 
the NSRS avoids limitations of other instruments.  This can only be achieved by 
demonstrating its reliability and validity within a clinical sample.   
The current study will provide a rigorous assessment of the convergent 
validity of the NSRS by examining its relationship to behavioral coding of expressed 
facial affect.  Specifically, the relationship between expressed facial affect and 
clinical ratings of blunted affect and other negative symptoms are explored.  
Consistent with findings that the NSRS was not related to depression or psychotic 
symptoms, it was also predicted that behavioral ratings of facial affect would n t be 




the relationship between expressed facial affect and functioning.  Thus, the current 
study will provide new information about the validity of an important negative 
symptom instrument as well as contribute to current understanding of functional 
deficits within schizophrenia. 
 
Hypotheses 
Aims and hypotheses are as follows: 
1. Aim 1 was to assess the convergent validity of the NSRS.  This aim was 
addressed in two ways.  First, behavioral displays of facial affect during an 
interview were coded and subsequently related to the NSRS.  It was 
hypothesized that behavioral codings of expressed facial affect would be 
negatively associated with clinically-rated blunted affect on the NSRS such 
that lower expressed facial affect will be associated with higher clinical 
ratings of blunted affect on the NSRS.  In addition, due to the high correlation 
among negative symptoms, it was predicted that behavioral coding of facial 
affect would also correlate negatively with all subscales of the NSRS.   
2.  The second aim examined whether specific facets of the behavioral coding of 
facial affect (i.e., duration, intensity, and frequency of facial affect) were more 
strongly related to clinical ratings of blunted affect.  This exploratory aim 
provides important insights as to what type of information clinical raters are 
most reliant on determining blunted affect scores, which may aid in further 




3. In a pilot study of the NSRS, it was determined that the measure was 
independent of psychotic and depressed symptoms.  Similarly, it was 
hypothesized that psychotic symptoms and depression would not be related to 
behavioral ratings of expressed facial affect.  
4. Finally, the relationship between behavioral coding of facial affect and 
functional outcome was explored.  It was predicted that greater intensity, 
duration and frequency of facial affect would be positively associated with 
functional outcome.   
 
 
Chapter 3: Method 
Design and Methodology 
Participant Recruitment and Inclusion/Exclusion Criteria 
Data from the current study were derived from a larger study aiming to assess 
reliability and validity of the NSRS.  Participants were recruited from the Mental 
Health Service Lines at the Baltimore Veterans Administration Medical Center 
(VAMC), the Perry Point VAMC, the Walter P. Carter Center, and the Maryland 
Psychiatric Research Center (MPRC).  Participants included 38 outpatients diagnosed 
with schizophrenia or schizoaffective disorder.  Inclusion criteria are as follows: (1) 
diagnosis of schizophrenia or schizoaffective disorder as determined by medical 
record review, and (2) age between 18 and 65 years.  Exclusion criteria are as 
follows: (1) documented history of severe neurological disorder or severe head 




and (3) inability to effectively participate due to intoxication or psychiatric symptoms 
as determined by the study interviewer.  
Procedure 
Mental health clinicians employed at the Baltimore and Perry Point VAMCs, Walter 
P. Carter Center, and the MPRC were familiarized with the study aims and 
inclusion/exclusion criteria.  Then, we asked mental health clinicians to identify 
patients diagnosed with schizophrenia or schizoaffective disorder who were 
potentially interested in participating in the current study.  If the participant met study 
inclusion and exclusion criteria, as determined by the mental health clinician, he/she 
were referred to the study interviewer who provided the participant with a description 
of the study procedures and obtained informed consent.  After providing consent, 
participants underwent a full assessment battery including demographic information, 
measures assessing negative symptoms, social functioning, general psychopathology 
and self-reported depressive symptomatology.  Assessments were conducted by 
masters-level interviewers who achieved adequate reliability for each of the measures 
in the assessment battery.  In order to ensure ratings made for one measure (i.e., 
NSRS) were not biased with information provided in another measure (i.e., SANS), 
independent interviewers administered the two negative symptom measures.  All 
interviews were videotaped for later evaluation by an independent second rater in 
order to check rater agreement.  The entire assessment lasted approximately 2 hours, 
and participants were compensated $25 for their time.  
     Of the 38 videotaped interviews, 6 videotapes were compromised (i.e., the 




Thus, no data could be collected on these 6 participants.  This left a final sample of 32 
participants.  Participants’ videotapes were reviewed and coded using the Facial 
Expression Coding System (FACES).  Originally, the FACES analyses were planned 
on two separate sections of the NSRS (the anhedonia and blunted affect subscales).  
These sections were chosen because they include questions that elicit emotional 
responses (i.e., “Tell me how you would feel if you spent time with your friends this 
week”) and, thus, were the most likely portions of the interview to include displays of 
facial affect.  Prior research studies have found adequate results with approximately 
4-6 minutes of sampling (Kring & Neale, 1996; Kring et al., 1993); 2 portions of the 
interview that are each 5 minutes in length are an appropriate amount of time for 
coding.  However, once analyses were underway, it was determined that many 
participants did not have 5 full minutes of interview for the blunted affect section.  
Length of interview ranged from 0 seconds to 5 minutes with an average of 1 minute 
and 11 seconds.  Because the amount of interview available for coding was so varied, 
and rating would be impossible to perform on a subgroup of participants (i.e., those 
with less than 1 minute), it was determined that the FACES ratings for the blunt d 
affect section should be excluded from the current study.  Subsequent analyses were 
conducted on the anhedonia section of the NSRS interview, which consisted of the 
first 5 minutes of the Anhedonia section of the interview.  The anhedonia subsection 
elicits a discussion of pleasurable activities and allowed the participant a chance to 
express emotion.   
For FACES ratings, agreement between the two coders was established during 




During the training period, coders were supervised by Dr. Blanchard and discussed 
the procedures for the facial expression ratings.  Once all coders had an understanding 
of how to accurately rate these dimensions, they began rating tapes individually, and 
agreement was calculated statistically across the entire set of ratings (as described 
below).  All videotapes were rated independently by two separate coders.  Raters
were blind to the participants’ ratings on the NSRS and other study measures.  All 




Various symptom assessments were utilized in the current study to determine 
their relationship with the NSRS and expressed facial affect.  Negative symptoms 
were evaluated utilizing the NSRS. The BPRS provided information regarding 
general level of current psychopathology and psychotic symptoms.  Depression wa  
assessed with the Calgary Depression Scale for Schizophrenia (CDSS: Addington, 
Addington, & Maticka-Tyndale, 1992).   
 Negative Symptom Rating Scale (NSRS; Kirkpatrick et al., 2006; Mueser, 
Sayers, Schooler, Mance, & Haas, 1994):  The NSRS is a 25-item interview measure 
designed to assess the severity of negative symptoms in schizophrenia and 
schizoaffective disorder over the previous week.  Each item is rated on a seven point 
scale ranging from “absent” to “severe.”  A more detailed listing of these it ms was 
provided earlier in this document.  These items combine to create five subscales 




from the first pilot study of the NSRS indicate that the measure demonstrates good 
reliability, discriminant validity and convergent validity with other negative symptom 
measures (See Appendix A for the full instrument). 
 Brief Psychiatric Rating Scale (BPRS; Overall & Gorham, 1962):  The BPRS 
is a 20-item interview measure designed to assess current clinical symptomatology as 
experienced over the previous week.  Items are rated on a seven point scale ranging 
from “not reported” to “very severe.”  A recent meta-analysis evaluating the factor 
structure of the BPRS recommended use of five subscales (Shafer, 2005).  These 
include Affect (e.g., anxiety, guilt feelings, depressive mood, and somatic concern), 
Positive Symptoms (e.g., unusual thought content, conceptual disorganization, 
hallucinations, and grandiosity), Negative Symptoms (e.g., blunted affect, emotional 
withdrawal, and motor retardation), Resistance (e.g., hostility, uncooperativeness, 
suspiciousness) and Activation (e.g., excitement, tension, and mannerisms-posturing). 
Psychometric properties of the BPRS are well-established (see Appendix B for full 
measure; Anderson, Larsen & Schultz, 1989; Morlan & Tan, 1998; Overall & 
Gorham, 1962). 
 Calgary Depression Scale for Schizophrenia (CDSS; Addington et al., 1992): 
The CDSS is a 9-item semi-structured interview measure specifically designed to 
assess depressive symptoms in people diagnosed schizophrenia.  This measure 
assesses symptoms experienced over the previous two weeks including depression, 
hopelessness, self depreciation, guilty ideas of reference (excluding delusions of 
guilt), pathological guilt, morning depression, early wakening, suicide and 




from “absent” to “severe.”  Multiple studies have demonstrated the ability of this 
measure to assess depressive symptoms separate from positive, negative and 
extrapyramidal symptoms in people with schizophrenia setting it apart from other 
depression measures used in the evaluation of this population (Addington, Addington, 
Maticka-Tyndale, 1992; Addington, Addington & Atkinson, 1996; Collins, 
Remington, Coulter & Birkett, 1996).  The CDSS has demonstrated high internal 
consistency and good inter-rater reliability (see Appendix C for full measure; 
Addington, Addington & Schissel, 1990; Addington, et al., 1992). 
 
Functioning Measure 
Social Functioning Scale (SFS; Birchwood, Smith, Cochran, Wetton, & 
Copestake, 1990): The SFS is an 81-item self-report questionnaire designed to assess 
social behavior and community functioning in those with schizophrenia.  This scale 
inquires about functioning in seven areas including social engagement/withdrawal 
(e.g., “How often do you start a conversation at home?”), interpersonal behavior (e.g., 
“How many friends do you have at the present time?”), pro-social behavior (e.g., 
“How often have you gone to the movies in the last three months?”), recreation (e.g., 
“How often have you done an artistic activity in the last three months?”), 
independence-competence (e.g., “How able are you use public transportation?”), 
independence-performance (e.g., “ How often have you washed your own clothes in 
the past three months?”), and employment/occupation (e.g., “Are you currently 
working?”).  The SFS has demonstrated good reliability and validity in samples of 




1990).  In this study, the measure was administered as a verbal interview to ensure 
proper understanding of test items (see Appendix D for full measure).   
 
Behavioral Ratings of Expressed Facial Affect 
Facial Affect Coding System (FACES; Kring & Sloan, 1991; Kring & Sloan, 
2007).  The FACES system allows coding for duration, frequency, valence, intensity 
and predominant expression of facial displays during the period of coding.  The 
FACES system defines an expression in two different ways.  First, an expression is 
defined by either a change from a neutral display to a non-neutral display and then 
back to a neutral display.  Another definition is a change from a neutral display into a 
non-neutral display and then into another different affective display, which is coded 
as two different expressions.  The expression is first coded as either positive or 
negative (i.e., valence).  Then, coders rate the intensity of the expression on a 4-p int 
Likert scale (from 1 = “low” to 4 = “very high”).  Finally, coders note the duration of 
the expression.  At the end of the coding period, coders summarize the information 
for both the positive and negative expressions.  In order to calculate the frequency 
variable for positive expressions, the number of positive expressions is added 
together.  In order to attain the intensity variable for positive expressions, all intensity 
levels for positive expressions are added and then averaged over the positive 
expression frequency variable.  To compute the duration variable for positive 
expressions, the duration of each positive expression is added together and averaged 
over the positive expression frequency variable.  The same procedure is done for the 
negative facial expressions.  The FACES system has demonstrated good inter-rater 




in relation to other coding systems, self-report measures and clinician rated measures 
(see Appendix E for FACES manual and Appendix F for FACES summary sheet; 







Chapter 4: Results 
Sample Characteristics 
The final sample of participants (N = 32) had a mean age of 46.41±9.45.  
Demographics from the sample revealed that 87.5% were African-American, 9.4% 
were Caucasian, and 3.1% were Asian.  Further, 21.9% were female and 78.1% were 
male (see Table 1).  In terms of education attainment, 40.6% of the sample had 
attended some high school, 37.5% had graduated high school, 18.8% had attended 
some college, and 3.1% had completed graduate school.  In relation to employment, 
31.3% of the sample was employed, and 68.8% of the sample was unemployed.  
Further, 34.4% identified as military veterans.  In terms of medication status, 28.1% 
were prescribed a first-generation antipsychotic, 34.4% were prescribed a second 
generation antipsychotic, 6.3% were taking both a first and second generation 
antipsychotic, 6.3% were not taking medication, 3.1% were taking psychotropic 
medication other than antipsychotics, and 21.9% were missing data on their 
medication regimen primarily because they could not recall their medication when 
prompted by the interviewer.         
Analyses 
Procedures to Address Missing Data 
As mentioned previously, this study intended to examine frequency, intensity 
and duration ratings for both positive and negative facial affective displays.  After




this creates too small of a sample to conduct substantive analyses; therefore, negative
facial expressions are eliminated from subsequent analyses.  All following analyses 
will be conducted on positive facial affective displays only.   
Data was missing from the several of the scales.  In terms of the NSRS 
subscales, the Anhedonia subscale had data for 27 participants, the Asociality 
subscale had data for 29 participants, and the Avolition subscale had data for 26 
participants.  However, both the Blunted Affect subscale and the Alogia subscale had 
data for all 32 participants.  For the Calgary Depression Scale, data was avail ble for 
30 participants.  For the SFS, available data also varied depending on the subscale.  
For the Engagement/Withdrawal subscale there was data for 30 participants, the 
Interpersonal Behavior subscale had data for 28 participants, the Prosocial Behavior 
subscale had data for 31 participants, the Recreation subscale had data for 31 
participants, the Independence/Competence subscale had data for 29 participants, and 
the Independence/Performance subscale had data for 24 participants.  
 
FACES Variables 
As in previous studies that have utilized the FACES measure, inter-rater 
agreement for FACES ratings was calculated using an intra-class correlati n (ICC; 
Shrout and Fleiss, 1979).  Using this random-effects model, raters are treated as if 
selected from a random sample of raters, and each target is rated by a different set of 
k judges.  Three raters coded videotapes.   After training, two raters coded half of the 
videotapes (non-overlapping), with a third rater coding all videotapes.  Thus, there 
were two rater pairs with each rater coding half of the tapes paired with the rater who 




of the three separate variables (frequency, duration, and intensity).  ICCs for Pair 1 
ranged from .93 to .98 and from .89 to .99 for Pair 2, indicating excellent agreement 
(see Table 2).   
The FACES coding results in three variables: frequency, intensity and 
duration of facial expressions.  As in previous studies employing the FACES 
measure, the intensity and duration variables were averaged over the frequency 
variable in order to control for the effects of different numbers of facial expressions 
between participants. The frequency variable is not averaged.  This method is 
consistent with previous data analyses on FACES data (Kring & Sloan, 1991; Kring 
& Sloan, 2007).  For the FACES variables, the mean frequency of expressions was 
1.52±2.00, the mean duration in seconds was 2.88±3.74, and the mean intensity of 
expressions was .95±.96.  Subsequently, the frequency, intensity and duration 
variables were transformed into z-scores to ease interpretation given the differ nt 
metric of each scale.  This method is consistent with previous research on FACES 
(Kring & Sloan, 1991; Kring & Sloan, 2007).  
 
Correlations Among FACES Variables 
Correlations among the individual FACES variables of frequency, duration, and 
intensity were computed (see Table 3).  Correlations ranged from .59 to .78, and all of 
the individual FACES variables for positive expressions were significantly 
interrelated (p < .01).  While these intercorrelations are consistent with previous 
research studies employing FACES (e.g., Kring et al., 1993), they are not as high  
those seen in previous research (e.g., when participants watch a neutral film, 




Correlations Between FACES Variables and Negative Symptom Ratings 
 
In order to address the first hypothesis, expressed facial affect was correlated with 
symptom ratings of blunted affect on the NSRS.  As can been seen in Table 4, 
bivariate correlations revealed that the 3 FACES variables, frequency, intensity and 
duration, were negatively correlated with the NSRS blunted affect subscale at p < .01.  
Correlations ranged from -.42 to -.52 (see Table 4).  Therefore, the higher the clinical
rating of blunted affect, the less displayed facial affect.  Thus, an independent, 
behavioral measure of expressed facial affect correlated negatively with the NSRS 
blunted affect subscale.      
In order to address the second portion of this hypothesis, that expressed facial 
affect would correlate with the other subscales of the NSRS, bivariate correlati ns 
were performed to examine the relationship between the frequency, intensity and 
duration of expressed facial affect and the other 4 subscales of the NSRS, anhedonia, 
asociality, avolition and alogia.  Analyses revealed that no other subscales of th  
NSRS were significantly correlated with FACES ratings (see Table 4).  However, 
there were a few correlations that were of moderate effect size.  Specifically, there 
was a negative correlation between the Avolition subscale of the NSRS and the 
frequency of facial expression on FACES, r = -.30, p = .10. Additionally, the 
Avolition subscale of the NSRS negatively correlated with the Intensity of facial 
expressions on FACES, r = -.34, p = .08.  Issues surrounding power will be outlined 
further in the discussion section.   
In order to further examine the relationship between negative symptoms and 




magnitudes of correlations were compared between the following: the Blunted Affect 
and Asociality subscales for frequency, and the Blunted Affect and Avolition 
subscales for both the Intensity and Duration variables.  In terms of the Blunted 
Affect and Asociality subscales and the frequency variable, there was not a 
significant difference between the magnitudes of the correlations, z = .88, p = .37.   
Next, the magnitudes of the correlations for the Blunted Affect and Avolition 
subscales and the Intensity variable were examined and were not significant, z = .79, 
p = .42.  Finally, the difference between the correlation magnitudes for the Blunted 
Affect and Avolition subscales for Duration and it was not significant, z = .57, p = 
.56.  Thus, none of the correlation magnitude comparisons reached significance.  
The current study was part of a larger study examining the reliability and 
validity of the NSRS; thus, data for the SANS was available.  Exploratory analyses 
were conducted on the data to determine specific associations between SANS ratings 
and behavioral codings of expressed facial affect in this sample.  The SANS affective 
flattening subscale negatively correlated with both frequency (r = -.37, p < .05) and 
intensity (r = -.41, p < .05) of facial expressions.  Additionally, the SANS alogia 
subscale significantly correlated with the intensity of facial expression  (r = -.35, p < 
.05).  All other correlations did not reach significance.  Of interest, the affective 
flattening subscale, which is similar to the blunted affect subscale on the NSRS, only 
correlated with two of the three expressed facial affect domains, frequency and 
intensity, while the NSRS blunted affect subscale correlated with all three domains of 




significantly correlated with the intensity of facial expressions, the NSRS Alogia 
subscale did not.  These issues will be further discussed in the limitations section.       
 
Multiple Regression 
In terms of the second hypothesis, (i.e., to determine what aspect of facial 
expression drives clinical ratings of blunted affect), multiple regression was planned.  
However, given the high degree of multicollinearity among the predictor variables, 
the regression could not be performed.  Examination of the zero-order correlations 
revealed all three dimensions of behavioral coding were significantly associated with 
clinical ratings of blunted affect. 
Correlations between FACES ratings and Psychotic and Depressive Symptoms 
 
It was hypothesized that negative symptoms and FACES ratings would be 
independent of psychotic and depressive symptomatology.  To address this aim, 
bivariate correlations were conducted to determine the relationship between FACES 
ratings and psychotic and depressive symptomatology.  None of the FACES ratings 
correlated with the BPRS Thought Subscale or the Calgary Depression subscale (See 
Table 5).  Thus, as predicted, FACES ratings were not related to both psychotic and 
depressive symptoms.        
Correlations Between FACES Ratings and Functioning 
 
Finally, the relationship between FACES ratings with functional outcome was 
assessed.  Bivariate correlations revealed no significant associations in the predicted 
direction (see Table 6).  However, there was a significant correlation in the opposite 




Independence/Competence subscale of the Social Functioning Scale.  Thus, the more 
facial intensity a participant displayed, the less likely they were to be cmpetent in 
areas such as using public transportation and handling money.  It is possible that the 
lack of significant in these findings is due to the lack of power as mentioned above.   
 
 
Chapter 5:  Discussion 
This study sought to examine the convergent validity of the NSRS by 
exploring the relationship between clinician rated negative symptoms on the NSRS 
and behavioral coding of expressed facial affect.  As hypothesized, clinical rat ngs of 
blunted affect correlated negatively with behavioral coding of expressed facial affect.  
Thus, this finding provides convergent validity for the newly developed NSRS.  This 
research provides a substantial step forward in the validation of the NSRS as the gold-
standard rating scale for negative symptoms in schizophrenia.  A secondary aim of 
this study was to examine the relationship between behavioral coding of expressed 
facial affect and functional outcomes.  There was not a significant relationship 
between any of these variables.  The findings from the current study and their 
applicability to the extant literature are reviewed below. 
As hypothesized, a significant negative correlation was observed between 
clinician ratings of blunted affect on the NSRS and all variables of behavioral coding 
of facial affect.  Specifically, the higher a clinician rated a participant’s blunted affect 
(i.e., higher symptomatology), the less facial affect they displayed in the domains of 
frequency, intensity and duration.  Diminished facial expression (i.e., affective 




one of the DSM-IV diagnostic criteria for schizophrenia (American Psychiatric 
Association, 2000).  Recent studies of facial expression in schizophrenia have 
consistently noted reduced facial expression in this population (Berenbaum & 
Oltmanns, 1992, Kring et al., 1993, Kring & Neale, 1996, Tremeau, Malaspina, 
Duval, Correa, Hager-Bubny, Coin-Bariou, Macher, Gorman, 2005; Wolf et al., 
2006).  Thus, diminished facial expression, an objective rating, was negatively 
correlated with clinician ratings on the NSRS scale, which confirms the convergent 
validity of the scale.       
Because this is an initial pilot study of the NSRS, to date there is no literature 
regarding expressed facial affect and the NSRS.  However, there is a small literature 
regarding negative symptoms and expressed facial affect.  Additionally, the current 
study was able to utilize SANS ratings, which yielded results demonstratig that the 
SANS Affective Flattening subscale, which is similar to the Blunted Affect subscale 
of the NSRS, was associated with diminished frequency and intensity of facial 
expressions.   Both the NSRS and SANS findings in the current study are consistent 
with a previous research study that found a significant correlation between 
diminished facial expressiveness in schizophrenia and blunted affect as measured by 
the SANS affective flattening ratings (Troisi, Pompili, Binello, & Sterpone, 2007).  
Further, diminished facial affect in patients with schizophrenia correlated negativ ly 
with the BPRS anergia subscale, which is another measure of negative symptoms 
(Tremeau et al., 2005).  This finding is consistent with the findings in the present 
study.  However, in one study, the SANS affective flattening subscale score and the 




codings of expressed facial affect (Kring, 1993).  Thus, significant associations found 
in the current study between expressed facial affect and clinician ratings of blunted 
affect on negative symptom scales are largely consistent with previous research.  
Although one study found conflicting results, it is somewhat difficult to explain given 
the varied methods employed across studies including different facial affect coding 
systems, the type of behavior that was coded (i.e., interview, social interaction, or 
eliciting emotion via a film clip, etc.) and the use of the SANS or the BPRS to 
measure negative symptoms.  However, it is clear that the relationship between 
reduced facial expressivity and the blunted affect scale of the NSRS provides 
convergent validity for the newly developed NSRS scale.  These results further the 
work to establish the NSRS as a valid scale for the measurement of negative 
symptoms in schizophrenia.   
Due to the high correlation between blunted affect and other negative 
symptoms, it was hypothesized that behavioral coding of expressed facial affect 
would also correlate with negative symptoms.  None of the correlations between the 
remainder of the NSRS subscales and behavioral coding of expressed facial affe t 
were significant.  In exploratory analyses between the SANS and FACES ratings, a 
significant negative correlation was observed between the SANS subscale of Alogia 
and Intensity of facial expressions.  The literature regarding the relationship between 
negative symptoms and behavioral codings of expressed facial affect is mixed.  In a 
study employing the FACES measure to code the reactions to positive and negative 
emotional film clips in a population of those with schizophrenia, SANS total score 




The study did not provide further breakdowns regarding subscales of the SANS.  
Another study analyzed social role plays using the FACES measure and observed 
only a weak association between SANS total score and behavioral coding of 
expressed facial affect (Aghevli et al, 2003). While this research finding is consistent 
with the results of the current study, there are significant methodological differences 
in the previous research such as the methodology of eliciting emotional reactions to 
film clips and analyzing social role plays.  Interestingly, a previous study found a 
significant association between expressed facial affect, the SANS alogia subscale and 
the SANS total score (Troisi et al., 2007).  This research is consistent with the 
exploratory finding in the current study in which the SANS alogia subscale was 
associated with diminished intensity of facial expressions.  However, in the current 
study both the NSRS alogia subscale and SANS total score were not significantly 
correlated with behavioral codings of expressed facial affect.  Of note, there were 
significant methodological differences between this previous research and te current 
study.  The previous research prompted participants to imitate others’ facial 
expressions, to create a facial expression that captured an emotional word and to 
describe a recent event based off of an emotional word (Troisi et al., 2007).  Further, 
this research used a different facial affect coding system, the Facial Action Coding 
System, which is similar to FACES except that it employs further breakdowns f 
types of emotions and uses sums of scores instead of averages.  Thus, while findings 
in the literature are mixed, the results of the current study are largely consistent with 




In the current study, the lack of significant correlations between the NSRS 
subscales, other than the Blunted Affect subscale, and behavioral codings of 
expressed facial affect likely occurred because there was not enough power in the 
sample.  Using a medium effect size of d = .3, power was calculated on the sample.  
The total sample size ranged from 26 to 32 yielding power that ranged from .60 to 
.68. Thus, the power of the study was not sufficient to detect even medium effect 
sizes.  Issues surrounding power will be examined further in the limitations section.  
Results were consistent with the prediction that behavioral codings of 
expressed facial affect would not be related to psychotic or depressive symptoms. 
Consistent with the current study, two previous studies investigating the relationship 
between expressed facial affect and symptoms of schizophrenia did not find any 
association between psychotic symptoms and expressed facial affect (Tremeau t al., 
2005; Troisi et al., 2007).  Additionally, depression was not related to expressed 
facial affect in a previous study (Troisi et al., 2007), which is consistent with the 
results of the current study.     
A secondary aim of this study was to assess the relationship between 
behavioral coding of facial affect and functional outcomes.  It was predicted that there 
would be a positive correlation between all domains of expressed facial affect and 
functional outcomes.  Unexpectedly, no correlations reached significance in the 
predicted direction, which could be explained by several factors.  First, certain 
correlations likely did not reach significance because the sample did not have enough
power.  In these analyses, the sample size ranged from 24 to 31.  Power analyses 




the lack of findings could also be due to the type of behavior that was analyzed.  In 
this study, coding was completed on an interview not a social interaction.  A social 
interaction may have mimicked a real world situation, which, in turn, could have 
highlighted this relationship.  The lack of findings for this aim could also be due to 
the measurement used to assess functioning.  Measurements relied solely on patient 
self-report, which often does not correlate with observer ratings of functioning 
(Bowie, Twamley, Anderson, Halpern, Patterson, & Harvey, 2007).  These issues are 
outlined further in the limitations section. Further, the finding, in the opposite of the 
predicted direction that greater facial intensity was associated with reduced capacity 
to function in areas such as handling money and using public transportation was 
unexpected.  Again, this finding could be influenced by inaccurate self reporting of 
current functioning (Bowie, et al., 2007).  In summation, the lack of significant 
findings in the predicted direction were unexpected and could be due to the 
methodology used to elicit emotional responding or inaccuracies in self-reports of 
current functioning.                          
Recently, another group investigated the relationship between expressed facial 
affect and functional outcomes in a sample of patients with schizophrenia (Troisiet 
al., 2007).  Diminished facial expression explained more variance in social and 
vocational outcomes than negative symptoms (Troisi, et al., 2007).  Thus, while the 
current study did not yield significant results in these domains, other research 
suggests that expressed facial affect significantly impacts functional outcome.  The 
results of the current study should be replicated in a large sample that would provide 





While this study has major strengths such as an ethnically diverse patient sample and 
the utilization of a new measure for negative symptoms, it also has notable 
limitations.  Limitations in this study include: the evolution of the NSRS across data 
collection, the unexpected lack of data points for negative facial expressions, the 
small sample size, the inability to examine gender differences due to the small sample 
size, the influence of medication on facial expression and self-report measures of 
functioning.  First, while the use of a newly developed measure is a strength of the 
study due to the limitations of widely used negative symptom measures, the 
administration of the measure evolved over the course of the study.  Most notably, 
when the first interviews of the NSRS were administered, all questions from the 
blunted affect section were administered.  Subsequently, it was determined that if the 
clinician had obtained that information elsewhere during the interview, they did not 
need to ask all questions outlined in the blunted affect section.  This change in 
administration impacted the current study because there was not enough data for
coding in the blunted affect section.  Thus, the blunted affect section was dropped 
from the study, and all analyses were conducted on the anhedonia portion of the 
interview.  Overall, the measure was being refined during the course of the current 
study and may have affected the results.  Due to this issue, there was not adequate 
power for the statistical analyses.  As mentioned previously, inadequate power likely 
affected significance values for the correlations between some of the other negative 
symptom domains and behavioral coding of affect as well as some of the 




Second, there were very few data points for negative expressions.  This is 
likely because the anhedonia section was used for coding.  This section of the 
interview asks participants to recount recent pleasurable experiences.  Thus, this 
evoked positive emotion and few negative facial expressions were observed.  The 
findings of the current study diverge from the literature on this topic.  Schizophrenic 
populations tend to display more negative affect than controls (Berenbaum & 
Oltmanns, 1992; Martin, Borod, Alpert, Brozgold, & Welkowitz, 1990).  However, 
one study noted an increase in positive facial expressions amongst patients with 
schizophrenia even in reaction to negative stimuli (i.e., a sad face; Falkenberg, Bartels
& Wild, 2007).  The authors interpreted this finding in light of other research stating 
that those with schizophrenia experience difficulties processing emotional stimu i, 
which may cause them to interpret the sad face as a neutral face.  In the current st dy 
there were few data points for negative expressions, which likely resulted from 
methodological differences between elicitation of affect in the current study versus 
previous research.  As a result of the limited negative expressions, analyses were only 
conducted on positive facial expressions, which may have affected the current 
findings.  Therefore, the results should be interpreted in light of this distinction. 
 In addition to losing data points due to dropping the blunted affect subsection 
and lack of negative facial expressions, the small sample size was a further limitation.  
While the original aim was to collect data points on 38 participants, videotape issues 
dropped that number to 32 participants that had adequate videotape for coding.  The 
small sample size likely influenced the results of the study because there was not 




FACES variables and NSRS subscales as well as FACES variables and curret 
functioning.  Thus, small sample size was a limitation in the current study.      
 A further limitation of the current study was the inability to conduct gender 
analyses.  The majority of the sample was male (i.e., 78.1%), which did not allow for 
gender analyses to be conducted.  Research conducted on emotional expression in 
healthy samples have repeatedly noted gender differences (Brody & Hall, 2000; 
Fischer, 1993).  Additionally, gender differences in course, functioning, and 
symptomatology of schizophrenia are outlined in the literature (Thorup, Petersen, 
Jeppesen, Ohlenschlaeger, Christensen et al., 2007).  Thus, it is likely that gender 
differences could have influenced the results of this study.  Because genderis an 
important aspect of both emotion and schizophrenia, the current study should be 
replicated in either a larger sample that allows for gender analyses or on a sample of 
women.   
 Another limitation of the current study was the possible effect of medication 
on expressed facial affect.  The majority of the sample was taking some type of
neuroleptic medication.  Neuroleptic, or antipsychotic, medications have the potential 
to cause a wide variety of side effects such as extrapyramidal symptoms, which 
include muscle contractions (i.e., acute dystonia), involuntary movements (i.e., 
tardive dyskinesia), tremors and rigidity (i.e., Parkinsonian-like symptoms) and body 
restlessness (i.e., akathisia) (Janicak, Davis, Preskor, Ayd, Marder & Pavuluri, 2006).  
These side effects could influence expressed facial affect in the current study. Thus, 
it is possible that neuroleptic medication influenced expressed facial affect, whi h 




 Another limitation of the current study is the method employed to measure 
current functioning.  The SFS is a self-report scale that relies on the patient’s report of 
their current functioning.  Recent research suggests that those with schizophrenia may 
overestimate or underestimate their level of functioning when compared to their cas  
manager’s assessment of their functioning (Bowie, Twamley, Anderson, Halpern, 
Patterson, & Harvey, 2007; Taylor & Langdon, 2007).  Therefore, it is unclear 
whether ratings of functioning in the current study reflect true, real-world 
functioning.  Thus, current functioning may best be assessed using multiple measures 
that tap several different sources of information.     
Future Directions and Conclusions 
The current research study provides evidence for the convergent validity of the NSRS 
as a gold-standard measure for the treatment of negative symptoms.  As mentioned 
previously, one limitation of this study is the limited sample size.  Future resea ch 
should seek to replicate these findings in a larger sample.  A larger sample size could 
provide adequate power for analyses that were of trend significance and further 
gender analyses.  Additionally, future replications should seek to code interviews that 
specifically probe for negative emotional experiences.  This methodology would 
allow for expressions of negative affect that would yield sufficient data points f r 
analyses.  Further, multiple modalities should be employed to assess current 
functioning in order to attain accurate measurement of this construct.  Thus, 
addressing limitations of the current research in future replications will trengthen 




 In summation, the current study aimed to assess the convergent validity of the 
NSRS by examining the relationship between behavioral codings of facial affect and 
clinician ratings of blunted affect on the NSRS.  The results of the current study 
suggest that the NSRS evidences good convergent validity.  Currently, a large sc le 
study is underway to assess the validity and reliability of the NSRS.  First, the initial 
version of the NSRS will be administered to 100 participants with schizophrenia and 
schizoaffective disorder.  The results of this study will be used to make data driven 
refinements to the measure.  After the NSRS is revamped accordingly, it will be 
administered to 300 patients with schizophrenia and schizoaffective disorder.  The 
validity and psychometric properties of the measure will be assessed in this sample.  
This study will also examine the relationship between negative symptoms and 
functional outcomes in schizophrenia.  This research represents a substantial step 
forward in the creation of a new, psychometrically sound instrument for the 
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Appendix A: Negative Symptom Rating Scale 
 
I. ANHEDONIA SUBSCALE 
 
A.  Pleasure during social activities 
 
1.  Highest intensity of pleasure during any social activity 
 0 – Strong or very intense pleasure 
 1 – Fairly strong pleasure 
 2 – Moderate pleasure 
 3 – Mild pleasure 
 4 – Slight pleasure 
 5 – Very slight pleasure 
6 – No pleasure in any social context and complete emotional indifferenc  to 
people 
 
2.  Frequency of pleasurable social activities 
 0 – Very often: Many pleasurable experiences 
 1 – Frequently: several pleasurable experiences 
 2 – Often: Some pleasurable activieis 
 3 – Sometimes: A few pleasurable experiences 
 4 – Occasionally: One or two pleasurable experiences 
5 - Rarely: Hardly any pleasurable experiences 
6 – Never: No pleasurable experiences 
 
B.  Pleasure expected (anticipated) from future social activities 
 
3.  Highest intensity of expected pleasure from future social activities 
 0 – Strong or very intense pleasure 
 1 – Fairly strong pleasure 
 2 – Moderate pleasure 
 3 – Mild pleasure 
 4 – Slight pleasure 
 5 – Very slight pleasure 
6 – No pleasure expected in future social context activities; completely 
indifferent about future social activities.  
 
4.  Highest intensity of pleasure during any physical sensation 
 0 – Strong or very intense pleasure 
 1 – Fairly strong pleasure 
 2 – Moderate pleasure 
 3 – Mild pleasure 
 4 – Slight pleasure 
 5 – Very slight pleasure 
6 – No pleasure from any physical sensations, and complete emotional 





5.  Frequency of pleasurable physical sensations 
 0 – Very often: Many pleasurable experiences 
 1 – Frequently: several pleasurable experiences 
 2 – Often: Some pleasurable activieis 
 3 – Sometimes: A few pleasurable experiences 
 4 – Occasionally: One or two pleasurable experiences 
5 - Rarely: Hardly any pleasurable experiences 
6 – Never: No pleasurable experiences 
 
D.  Pleasure expected (anticipated) from future physical sensations. 
 
6.  Highest intensity of expected pleasure from future physical sensations 
 0 – Strong or very intense pleasure 
 1 – Fairly strong pleasure 
 2 – Moderate pleasure 
 3 – Mild pleasure 
 4 – Slight pleasure 
 5 – Very slight pleasure 
6 – No pleasure expected from future physical sensations or activities; 
completely indifferent about future physical activities or sensations  
 
E.  Pleasure from recreational/vocational activities   
 
7.  Highest intensity of pleasure during any recreational/vocational activities 
 0 – Strong or very intense pleasure 
 1 – Fairly strong pleasure 
 2 – Moderate pleasure 
 3 – Mild pleasure 
 4 – Slight pleasure 
 5 – Very slight pleasure 
6 – No pleasure expected from recreational/ vocational activities; completely 
indifferent to recreational/vocational activities 
 
8.  Frequency of pleasurable recreational/vocational activities 
 0 – Very often: Many pleasurable experiences 
 1 – Frequently: several pleasurable experiences 
 2 – Often: Some pleasurable activieis 
 3 – Sometimes: A few pleasurable experiences 
 4 – Occasionally: One or two pleasurable experiences 
5 - Rarely: Hardly any pleasurable experiences 
6 – Never: No pleasurable experiences 
 






9. Highest intensity of expected pleasure from future recreational/vocational activities 
 0 – Strong or very intense pleasure 
 1 – Fairly strong pleasure 
 2 – Moderate pleasure 
 3 – Mild pleasure 
 4 – Slight pleasure 
 5 – Very slight pleasure 
6 – No pleasure expected from future recreational/ vocational activities; 
completely indifferent to recreational/vocational activities 
 
II.  ASOCIALITY SUBSCALE 
 
A.  Family 
 
10.  Family Relationships 
 0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 
 6 – severe deficit 
 7 – not rated: no living family 
 
B. Romantic Relationships 
 
11.  Romantic Relationships 
 0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 
 6 – severe deficit 
  
C.  Friends 
 
12.  Friendships 
  0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 





III. AVOLITION SUBSCALE 
 
A.  Social Interactions 
 
13.  Social Interactions 
 0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 
 6 – severe deficit 
 
B.  Work/Vocational/School Activities 
 
14.  Work/Vocational/School Activities 
 0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 
 6 – severe deficit 
 7 – not rated: subject is in the hospital for the duration of the rating period 
 
C.  Recreation/Hobbies/Pastimes 
 
15.  Recreation/Hobbies/Pastimes 
 0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 
 6 – severe deficit 
 
D.  Self-Care 
 
16.  Self-Care 
 0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 





IV. BLUNTED AFFECT SUBSCALE 
 
A.  Facial Expression 
 
17.  Facial Expression 
0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 
 6 – severe deficit 
 
B.  Vocal Expression 
 
18.  Vocal Expression 
 0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 
 6 – severe deficit 
 
C.  Expressive Gestures 
 
19.  Expressive Gestures 
 0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 
 6 – severe deficit 
 
D.  Eye Contact 
 
20.  Eye Contact 
 0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 





E.  Spontaneous Movements 
 
21.  Spontaneous Movements 
 0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 
 6 – severe deficit 
 
F.  Blunted Affect Subscale: Basis of Rating 
 Emotional prompts 
 Other interview questions 
 Both 
 
V. ALOGIA SUBSCALE 
 
A.  Quality of speech 
 
22.  Quality of speech 
 0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 
 6 – severe deficit 
 
B.  Spontaneous Elaboration 
 
23.  Spontaneous elaboration 
 0 – no impairment 
 1 – very slight deficit 
 2 – mild deficit 
 3 – moderate deficit 
 4 – moderately severe deficit 
 5 – marked deficit 




OPTIONAL ITEMS:  
 





24.  Experience of negative emotion 
 0 – Very often 
 1 – Frequently 
 2 – Often 
 3 – Sometimes 
 4 – Occasionally 
 5 – Rarely 
 6 – Never 
 
JUDGMENT OF CAUSE ITEM 
 
25.  Judgment of cause 
Based on all available information, what is your judgment as to the principal cause of 
the negative symptoms?  Choose either 1, 2, or 3 
 
1 – The negative symptoms are mostly primary rather than secondary to the 
factors in B, below 
2 – The negative symptoms are mostly secondary to the factors bel w.  If 
choosing 2, choose only one from a through e.  If you think more than one 
makes a significant contribution, pick the most important factor. 
  a.  Depression and/or anxiety 
  b.  Suspiciousness 
  c.  Other hallucinations and/or delusions 
  d.  Disorganization 
  e.  Medication side effect or a general medical condition 
  f.  Missing 




















Appendix B: Brief Psychiatric Rating Scale 
 
Directions: There are 20 items to be rated. The starred items (Items 3, 4, 6, 7, 13, 14, 
16, 17, 18 and 19) should be rated on the basis of observations made during the 
interview. For these items. 1 = Not observed. The remaining items should be rated on 
the basis of reported (i.e., subjective) information pertaining to the past week. For 
these items, 1 = Not reported. 
 
1. Somatic Concern: During the past week how has your physical health been? Do 
you feel you are physically ill in any way?(What do you think is wrong?) (How 
serious is it?) Have you worried about your health recently? Degree of concern over 
present bodily health. Rate the degree to which physical health is perceived as a 
problem by the patient whether complaints have a realistic basis or not. Do not rate 
mere reporting of somatic symptoms. Rate only concern for (or worrying about) 
physical problems (real or imagined). Rate on the basis of reported (i.e. subjective) 




Very Mild: occasionally is somewhat concerned about body, symptoms or physical 
illness 
 
Mild: occasionally is moderately concerned, or often is somewhat concerned 
 
Moderate: occasionally is very concerned, or often is moderately concerned 
 
Moderately Severe: often is very concerned 
 
Severe: is very concerned most of the time 
 
Very Severe: is very concerned nearly all of the time 
 
Cannot be assessed adequately because of severe formal thought disorder, 
uncooperativeness, or marked evasiveness/guardedness or; Not assessed 
 
2. Anxiety: During the past week have you felt very frightened or anxious? Have you 
worried a lot? (What do you worry about?) Have you had the feeling that something 
terrible might happen? Worry, fear, or overconcern for present or future. Rate solely 
on the basis of verbal report of patient's own subjective experiences. Do not infer 
anxiety from physical signs or from neurotic defense mechanisms. Do not rate if 









Mild: occasionally feels moderately anxious, or often feels somewhat anxious 
 
Moderate: occasionally feels very anxious, or often feels moderately anxious 
 
Moderately Severe: often feels very anxious 
 
Severe: feels very anxious most of the time 
 
Very Severe: feels very anxious nearly all of the time 
 
Cannot be assessed adequately because of severe formal thought disorder, 




3. Emotional Withdrawal: Deficiency in relating to the interviewer and to the 
interview situation. Overt manifestations of this deficiency include poor/Abe of eye 
contact, failure to orient oneself physically toward the interviewer, and a general lack 
of involvement or engagement in the interview. Distinguish from BLUNTED 
AFFECT, in which deficits in facial expression, body 




Very Mild: e.g., occasionally exhibits poor eye contact 
 
Mild: e.g., as above, but more frequent 
 
Moderate: e.g., exhibits little eye contact, but still seems engaged in the interview and 
is appropriately responsive to all questions 
 
Moderately Severe: e.g., stares at floor or orients self away from interview r, but still 
seems moderately engaged 
 
Severe: e.g., as above, but more persistent or pervasive 
 
Very Severe: e.g., appears "spacey" or "out of it" (total absence of emotional 
relatedness), and is disproportionately uninvolved or unengaged in the interview 
 
Cannot be assessed: (e.g., scored from audiotape) 
 
4. Conceptual Disorganization: Degree of speech incomprehensibility. Include any 
type of formal thought disorder (e.g., loose associations, incoherence, flight of ideas,
neologisms). DO NOT include mere circumstantiality or pressured speech, ven if 




thoughts are racing, I can't hold a thought," "my thinking gets all mixed up"). Rate 




Very Mild: e.g., somewhat vague, but of doubtful clinical significance 
 
Mild: e.g., frequently vague, but the interview is able to progress smoothly 
 
Moderate: e.g., occasional irrelevant statements, infrequent use of neologisms, or 
moderate loosening of associations 
 
Moderately Severe: as above, but more frequent 
 
Severe: formal thought disorder is present for most of the interview, and the interview 
is severely strained 
 




5. Guilt Feelings: During the past week have you been blaming yourself for 
anything? Have you been feeling guilty? (Do you feel that you deserve punishment?) 
(Have you been thinking about this a lot?) Overconcern or remorse for past behavior. 
Rate on the basis of the patient's subjective experiences of guilt as evidenced by 





Very Mild-occasionally feels somewhat guilty 
 
Mild: occasionally feels moderately guilty, or often feels somewhat guilty 
 
Moderate: occasionally feels very guilty, or often feels moderately guity 
 
Moderately Severe: often feels very guilty 
 
Severe: feels very guilty most of the time, or encapsulated delusion of guilt 
 
Very Severe: agonizing constant feelings of guilt, or pervasive delusions(s) f guilt 
 
Cannot be assessed: adequately because of severe formal thought disorder, 





6. Tension: Rate motor restlessness (agitation) observed during the interview. DO 
NOT rate on the basis of subjective experiences reported by the patient. Disregard 




Very Mild: e.g., occasionally fidgets 
 
Mild: e.g., frequently fidgets 
 
Moderate: e.g., constantly fidgets, or frequently fidgets, wrings hands and pulls 
clothing 
 
Moderately Severe: e.g., constantly fidgets, wrings hands and pulls clothing 
 
Severe: e.g., cannot remain seated (i.e., must pace) 
 
Very Severe: e.g., paces in a grantic manner 
 
Cannot be assessed: (e.g., scored from audiotape) 
 
7. Mannerism and Posturing: Unusual and unnatural motor behavior. Rate only 
abnormality of movements; do not rate simple heightened motor activity here. 





Very Mild: odd behavior but of doubtful clinical significance, e.g. occasional 
unprompted smiling, infrequent lip movements 
 
Mild: strange behavior but not obviously bizarre, e.g., infrequent head-tilting (side to 
side) in rhythmic fashion, intermittent abnormal finger movements 
 
Moderate e.g. assumes yoga position for a brief period of time, infrequent lounge 
protrusions, rocking 
 
Moderately Severe: e.g., assumes and maintains yoga position throughout interview, 
unusual movements in several body areas 
 
Severe: as above, but more frequent, intense, or pervasive 
 
Very Severe: e.g., bizarre posturing throughout most of the interview, continuous 
abnormal movements in several body areas 
 





8. Grandiosity: During the past week have you felt more self-confident than usual? 
Do you have any special abilities or talents? Do you feel there is a specil urpose or 
mission to your life? (Have you thought you might be somebody rich or 
famous?) Inflated self-esteem (self-confidence), or inflated appraisal of one's talents, 
powers, abilities, accomplishments, knowledge, importance, or identity. Do not score 
mere grandiose quality of claims (e.g., "I'm the worst sinner in the world," "The entire 
country is trying to kill me") unless the guilt/persecution is related to some special, 
exaggerated attributes of the 
individual. Also, the patient must claim exaggerated attributes; e.g., if patient denies 
talents, powers, etc., even if he or she states that others indicate that he/she has these 




Very Mild: e.g., is more confident than most people, but of only possible clinical 
significance 
 
Mild: e.g., definitely inflated self-esteem or exaggerates talents somewhat out of 
proportion to the circumstances 
 
Moderate: e.g., inflated self-esteem or exaggerates talents somewhat out of proportion 
to the circumstances, or suspected grandiose delusions(s) 
 
Moderately Severe: e.g., a single (definite) encapsulated grandiose delusion, or 
multiple (definite) fragmentary grandiose delusions 
 
Severe: e.g., a single (definite) grandiose delusion/delusional system, or multiple 
(definite) grandiose delusions that the patient seems preoccupied with 
 
Very Severe: e.g., as above, but nearly all conversation is directed toward the patient's 
grandiose delusion(s) 
 
Cannot be assessed adequately because of severe formal thought disorder, 




9.  Depressive Mood: In the past week have you had less interest in your usual 
activities? Have you felt sad or depressed? (Have you cried at all?) (How bad is the 
feeling?) (How long does it last?) Subjective report of feeling depressed, blue, "down 
in the dumps." etc. Rate only degree of reported depression. Do not rate on the basis 








Very Mild: occasionally feels somewhat depressed 
 
Mild: occasionally feels moderately depressed, or often feels somewhat depressed 
 
Moderate: occasionally feels very depressed, or often feels moderately depressed 
 
Moderately Severe: often feels very depressed 
 
Severe: feels very depressed most of the time 
 
Very Severe: feels very depressed nearly all of the time 
 
Cannot be assessed: adequately because of severe formal thought disorder, 
uncooperativeness, or marked evasiveness/guardedness, or Not assessed 
 
10. Hostility: During the past week have you been feeling irritable? How have you 
been getting along with other people? (Have you gotten in any arguments or fights?) 
Have you been easily annoyed or angered? (How strongly have you felt this way?) 
(How much of the time?) Animosity, contempt, belligerence, disdain for other people 
outside the interview situation. Rate solely on the basis of verbal report of feelings 
and actions of the patient toward others during the week. Do not infer hostility from 




Very Mild: occasionally feels somewhat angry 
 
Mild: often feels somewhat angry, or occasionally feels moderately angr  
 
Moderate: occasionally feels very angry, or often feels moderately angr or 
occasionally yells at others 
 
Moderately Severe: often feels very angry, often yells at others or occasi nally 
threatens to harm others 
 
Severe: has acted on his anger by becoming physically abusive on one or two 
occasions or makes frequent threats to harm others 
 
Very Severe: has been physically aggressive and/or required intervention to prevent 
assaultiveness on several occasions; or any serious assaultive act 
 
Cannot be assessed: adequately because of severe formal thought disorder, 





11. Suspiciousness: How did you get along with people in general during the past 
week? Do you feel that you have to be on guard with people? Has anyone been giving 
you a hard time, or accusing you of things? Has anyone deliberately tried to annoy 
you? Tried to harm you? 
Belief (delusional or otherwise) that others have now, or have had in the past, 
malicious or discriminatory intent toward the patient. On the basis of verbal report, 




Very Mild: rare instances of distrustfulness which may or may not be warranted by 
the situation 
 
Mild: occasional instances of suspiciousness that are definitely not warranted by the 
situation 
 
Moderate: more frequent suspiciousness, or transient ideas of reference 
 
Moderately Severe: pervasive suspiciousness, or frequent ideas of reference 
 
Severe: definite delusion(s) of reference or persecution that is (are) not wholly
pervasive (e.g. an encapsulated delusion) 
 
Very Severe: as above, but more widespread, frequent, or intense 
 
Cannot be assessed: adequately because of severe formal thought disorder, 
uncooperativeness, or marked evasiveness/guardedness, or Not assessed 
 
12. Hallucinatory Behavior: Have you had any unusual experiences during the past 
week? Do you seem to hear noises or voices when there's no one around and nothing 
else to explain it? Have you had visions, or seen things that others couldn't see? Is 
there anything unusual about the way things feel, or taste, or smell? (How often do 
you hear voices?) (Do your voices make it hard to concentrate?) (Do they tell you to 
do things?) Perceptions (in any sensory modality) in the absence of an identifiable 
external stimulus. Rate only those experiences that have 
occurred during the last week. DO NOT rate "voices in my head," or "visions in my





Very Mild: suspected hallucinations only 
 
Mild: definite hallucinations, but insignificant, infrequent or transient (e.g., 





Moderate: as above, but more frequent or extensive (e.g., frequently sees the devil's 
face, two voices carry on lengthy conversations) 
 
Moderately Severe: hallucinations are experienced nearly every day, or are a source 
of extreme distress 
 
Severe: as above, and has had a moderate impact on the patient's behavior (e.g., 
concentration difficulties leading to impaired work functioning) 
 
Very Severe: as above, and had had a severe impact (e.g. attempts suicide in response 
to command hallucinations) Cannot be assessed: adequately because of severe formal 
thought disorder, uncooperativeness, or marked evasiveness/guardedness, or Not 
assessed 
 
13. Motor Retardation: Reduction in energy level evidenced in slowed movements. 
Rate on the basis of observed behavior of the patient only; do not rate on the basis of 




Very Mild: and of doubtful clinical significance 
 
Mild: e.g. conversation is somewhat retarded, movements somewhat slowed 
 
Moderate: e.g. conversation is noticeably retarded but not strained 
 
Moderately Severe: e.g. conversation is strained, moves very slowly 
 
Severe: e.g., conversation is difficult to maintain, hardly moves at all 
 
Very Severe: e.g. conversation is almost impossible, does not move at all throughout 
the interview 
 
Cannot be assessed: (e.g., scored from audiotape) 
 
14. Uncooperativeness: Evidence of resistance, unfriendliness, resentment, and lack 
of readiness to cooperate with the interviewer. Rate only on the basis of the patient's 
attitude and responses to the interviewer and the interview situation; do not rate on 




Very Mild: e.g. does not seem motivated 
 





Moderate: e.g. monosyllabic, fails to elaborate spontaneously 
 
Moderately Severe: e.g. expresses resentment and is unfriendly throughout the 
interview 
 
Severe: e.g. refuses to answer a number most questions 
 
Very Severe: e.g. refuses to answer most questions 
 
Cannot be assessed 
 
15. Unusual Thought Content: Have you had any difficulty with your thinking in 
the past week? Do certain things have special meaning for you? (Give me an 
example) Is there any interference with your thoughts? Is there anything controlling 
your thoughts 
or movements? Do you see references to yourself in surprising places like on TV? 
Severity of delusions of any type - consider conviction and effect on actions. Assume 
full conviction if patient has acted on his or her beliefs. Rate on the basis of reported 




Very Mild: delusion(s) suspected or likely 
 
Mild: at times, patient questions his or her belief(s) (partial delusion) 
 
Moderate: full delusional conviction, but delusion(s) has little or no influence on 
behavior 
 
Moderately Severe: full delusional conviction, but delusion(s) has only occasional 
impact on behavior 
 
Severe: delusion(s) has significant effect e.g. neglects responsibilities because of 
preoccupations with belief that he/she is God 
 
Very Severe: delusion(s) has major impact e.g., stops eating because believs food is 
poisoned 
 
Cannot be assessed: adequately because of severe formal thought disorder, 
uncooperativeness, or marked evasiveness/guardedness, or Not assessed 
 
16. Blunted Affect: Diminished affective responsivity as characterized by deficits in 
facial expression, body gesture, and voice pattern. Distinguish from EMOTIONAL 
WITHDRAWAL in which the focus is on interpersonal impairment rather than affect. 







Very Mild: e.g. occasionally seems indifferent to material that is usually accompanied 
by some show of emotion 
 
Mild: e.g., somewhat diminished facial expression or somewhat monotonous voice or 
somewhat restricted gestures 
 
Moderate: e.g. as above but more intense, prolonged, or frequent 
 
Moderately Severe: e.g., flattening of affect including at least two of the three 
features ; severe lack of facial expression, monotonous voice, or restricted body 
gestures 
 
Severe: e.g., profound flattening of affect 
 
Very Severe: e.g., totally monotonous voice, and total lack of expressive gestures 
throughout the evaluation 
 
Cannot be assessed: (e.g., scored from audiotape) 
 
17. Excitement: Heightened emotional tone, including irritability and expansiveness 




Very Mild: and of doubtful clinical significance 
 
Mild: e.g., irritable or expansive at times 
 
Moderate: e.g., frequently irritable or expansive 
 
Moderately Severe: e.g., constantly irritable or expansive; or at times enraged or 
euphoric 
 
Severe: e.g. enraged of euphoric throughout most of the interview 
 
Very Severe: e.g., as above but to such a degree that the interview must be terminated 
prematurely 
 
Cannot be assessed 
 
18. Disorientation: Now I want to ask you some standard questions that we usually 
ask at this point; What is today's date? (What day of the week is it? What month? 
What day of the month? What year?) Where are we now? Confusion or lack of proper 







Very Mild: e.g. seems somewhat confused 
 
Mild: e.g. indicates 1982 when, in fact it is 1983 
 
Moderate: e.g. indicates 1978 
 
Moderately Severe: e.g. is unsure where he/she is 
 
Severe: e.g. has no idea where he/she is 
 
Very Severe: e.g. does not know who he/she is 
 
Cannot be assessed: Adequately because of severe formal thought disorder, 
uncooperativeness, or marked evasiveness/guardedness, or Not assessed 
 
19. Poverty of Speech: A restriction in the amount of spontaneous speech, i.e., 
conversation and answers to questions are either brief or un elaborated. Meaningful 




Very Mild: questionable 
 
Mild: occasional replies do not include elaborated information even when this is 
appropriate. 
 
Moderate: as above, but more frequently replies do not include elaborated 
information or occasional replies are monosyllabic or brief. 
 
Moderately Severe: at least half of the patients' replies are monosyllabic or brief. 
 
Severe: most answers are rarely more than a few words in length, and occasionally 
questions may be left unanswered. 
 
Very Severe: patients' answers are either monosyllabic or she/he fails to an wer 
questions. 
 
Cannot be assessed: adequately because of severe fromal thought disorder, 
uncooperativeness, or marked evasiveness/guardedness; or not assessed. 
 
20. Inappropriate Affect: Affect expressed is inappropriate or incongruous with the 




takes the form of smiling or assuming a silly facial expression while talking about a 




Very Mild: questionable 
 
Mild: at least one clear instance of inappropriate smiling or other inappropriate affect 
 
Moderate: at least two clear instances of inappropriate affect 
 
Moderately Severe: occasional to frequent instances of inappropriate affect 
 
Severe: frequent instances of inappropriate affect 
 
Very Severe: affect is inappropriate most of the time 
 
Cannot be assessed: adequately because of severe formal thought disorder, 


























Appendix C: Calgary Depression Scale for Schizophrenia 
 
Directions: Ask the first question as written.  Use follow up probes or qualifiers at 
your discretion.  Time frame refers to last two weeks unless stipulated.  The last it m, 
#9 is based on observations of the entire interview. 
 
1.  DEPRESSION: How would you describe your mood over the last two weeks?  Do 
you keep reasonably cheerful or have you been very depressed or low spirited 
recently?  In the last two weeks how often have you (own words) every day?  All 
day? 
 
 0 – Absent 
 1 – Mild – Expresses some sadness or discouragement on questioning 
2 – Moderate – Distinct depressed mood persisting up to half the time over 
last 2 weeks: present daily 
3 – Severe – Markedly depressed mood persisting daily over half the time 
interfering with normal motor and social functioning 
 
2.  HOPELESSNESS: How do you see the future for yourself? Can you see any 
future? - or has life seemed quite hopeless? Have you given up or does there still 
seem some reason for trying? 
 
 0 – Absent 
1 – Mild – Has at times felt hopeless over the past two weeks but still has 
some degree of hope for the future 
2 – Moderate – Persistent, moderate sense of hopelessness over last week.  
Can be persuaded to acknowledge the possibility of things being better. 
 3 – Severe – Persisting and distressing sense of hopelessness 
 
3.  SELF DEPRECIATION: What is your opinion of your self compared to other 
people? Do you feel 
better, not as good, or about the same as others? Do you feel inferior or even 
worthless? 
 
 0 – Absent 
 1 – Mild – Some inferiority, not amounting to feeling of worthlessness 
 2 – Moderate – Subject feels worthless, but less than 50% of the time. 
3 – Severe – Subject feels worthless more than 50% of the time.  May be 
challenged to acknowledge otherwise. 
 
4. GUILTY IDEAS OF REFERENCE: Do you have the feeling that you are being 
blamed for something or even wrongly accused? What about? (Do not include 
justifiable blame or accusation. Exclude delusions of guilt.) 
 
 0 – Absent 




2 - Moderate - Persisting sense of being blamed, and/or occasional sense of 
being accused. 
3 - Severe - Persistent sense of being accused. When challenged, 
acknowledges that it is not so. 
 
5. PATHOLOGICAL GUILT: Do you tend to blame yourself for little things you 
may have done in the past? Do you think that you deserve to be so concerned about 
this? 
 0 – Absent 
1 – Mild – Subject sometimes feels over guilty about some minor peccadillo, 
but less than 50% of the time. 
2 - Moderate - Subject usually (over 50% of the time) feels guilty about past 
actions the significance of which s/he exaggerates. 
3 - Severe - Subject usually feels s/he is to blame for everything that has gone 
wrong, even when not his/her fault. 
 
6. MORNING DEPRESSION: When you have felt depressed over the last 2 weeks 
have you noticed the depression being worse at any particular time of day? 
 0 - Absent - No depression. 
1  - Mild - Depression present but no diurnal variation. 
2  - Moderate - Depression spontaneously mentioned to be worse in a.m. 
3  - Severe - Depression markedly worse in a.m., with impaired functioning 
which improves in p.m. 
 
7. EARLY WAKENING: Do you wake earlier in the morning than is normal for you? 
How many times a week does this happen?  
 
 0 - Absent - No early wakening. 
1 - Mild - Occasionally wakes (up to twice weekly) 1 hour or more before 
normal time to wake or alarm time. 
2 - Moderate - Often wakes early (up to five times weekly) 1 hour or more 
before normal time to wake or alarm. 
3  - Severe - Daily wakes 1 hour or more before normal time. 
 
8. SUICIDE: Have you felt that life wasn't worth living? Did you ever feellik  
ending it all? What did you think you might do? Did you actually try? 
 
0 - Absent. 
1 - Mild - Frequent thoughts of being better off dead, or occasional thoughts 
of suicide. 
2 - Moderate - Deliberately considered suicide with a plan, but made no 
attempt. 
3 - Severe - Suicidal attempt apparently designed to end in death (i.e. 





9. OBSERVED DEPRESSION: Based on interviewer's observations during the entire 
interview. The question "do you feel like crying?" used at appropriate points in the 
interview, may elicit information useful to this observation. 
 
0 - Absent. 
1 - Mild - Subject appears sad and mournful even during parts of the 
interview, involving affectively neutral discussion. 
2 - Moderate - Subject appears sad and mournful throughout the interview, 
with gloomy monotonous voice and is tearful or close to tears at times. 
3 - Severe - Subject chokes on distressing topics, frequently sighs deeply or 
cries openly, or is persistently in a state of frozen misery if the examiner is 



























Appendix D: Social Functioning Scale 
 
Directions: This questionnaire helps us to learn how you have been recently.  It takes 
about 20 minutes to complete.  Before starting, please answer the following: 
 
1.  Where do you live? 
 
2.  Who do you live with? 
 
Social Engagement/Withdrawal Subscale: 
 
1.  What time do you get up? 
 
2.  How many hours of the day do you spend alone (e.g., alone in a room, walking out 
alone, listening to radio or watching TV alone)? 
 
3.  How often do you start a conversation at home? 
 
4.  How often do you leave the house (for any reason)?    
 
5.  How do you react to the presence of strangers? 
 
Interpersonal Communication Subscale: 
 
1.  How many friends do you have at the present time (people you see regularly, do 
activities with, etc.?) 
 
2.  Do you have a boyfriend/girlfriend (if not married)? 
 
3.  How often are you able to carry out a sensible or logical conversation? 
 
4.  How easy or difficult do you find it talking to people at the present time? 
 
Independence – Performance Subscale: 
 
Directions: Indicate how often each of the following was done during the past 3 
months. 
 
1. Buying items from stores without help 
 
2. Washing dishes, cleaning up, etc. 
 
3. Regular showering/bathing etc. 
 





5. Looking for a job (if unemployed) 
 
6. Doing the food shopping 
 
7. Preparing and cooking a meal 
 
8. Leaving the house alone 
 
9. Using buses, trains, etc. 
 




12. Choosing and buying clothes for self 
 




Directions:  How often has the respondent done each of the following in the last 3 
months: 
 
1. Playing musical instruments 
 






5. Watching television 
 




8. Do It Yourself activities (e.g., plumbing, carpentry) 
 



















Directions: How often has the respondent done each of the following in the last 3 
months: 
 




3. Watching an indoor sport (wrestling, basketball) 
 
4. Watching an outdoor sport (football, baseball) 
 




7. Visiting places of interest 
 
8. Meetings/talks etc. (count AA/NA meetings) 
 
9. Attending class 
 
10. Visiting relatives in their homes 
 
11. Being visited by relatives 
 




14. Formal occasions 
 
15. Dance club 
 
16. Nightclub/social club 
 











21. Eating out 
 
22. Church activity 
 
Independence – Competence: 
 
Directions: How able are you to do each of the following activities? 
 
1. Use public transportation 
 
2. Handle money 
 
3. Budget money 
 
4. Cook for self 
 
5. Do weekly shopping 
 
6. Look for a job 
 
7. Wash own clothes 
 
8. Take care of personal hygiene 
 
9. Wash, clean, etc. 
 
10. Buy things from stores 
 
11. Leave the house alone 
 
12. Choose and buy clothes 
 




1.  Are you currently working? (this includes job training courses/rehabilitation) 
 
2.  If Yes: 





 2b.  How many hours do you work each week? 
 
 2c.  How long have you had this job? (months) 
 
3.  If No: 
 
 3a.  When did you last work (in months)? 
 
 3b.  What kind of job was it? 
 
 3c.  How many hours did you work each week? 
 
4.  Do you collect payments for a physical or mental disability? 
 
5. Are you currently in outpatient treatment (i.e., attend a hospital/treatment center as 
a day patient)? 
 
6. Do you think that you are capable of some kind of employment/work? 
 





































































































































































Facial Affect Coding System Summary Sheet 
 
Subject ID:    Rater:     Film Type:   
            
 
Time start:    Time end:    Duration:    
 
Valence:    Positive:       Negative:   
 
Intensity: low  medium  high   very high 
  1                  2                3        4 
            
 
Time start:    Time end:    Duration:    
 
Valence:    Positive:       Negative:   
 
Intensity: low  medium  high   very high 
  1                  2                3        4 
           
  
 
Time start:    Time end:    Duration:    
 
Valence:    Positive:       Negative:   
 
Intensity: low  medium  high   very high 
  1                  2                3        4 
            
 
Time start:    Time end:    Duration:    
 
Valence:    Positive:       Negative:   
 
Intensity: low  medium  high   very high 
  1                  2                3        4 










What is the overall level of expressiveness for this person for this film clip? 
 
 Low  fairly low      medium        fairly high              high  
    1                          2                          3                       4                         5 
 
Number of positive expressions:     
 
Number of negative expressions:     
 
Mean intensity-positive:      
 
Mean intensity-negative:      
 
Duration of positive expressions:     (in seconds) 
 








Demographic Characteristics for the Patient Sample (N = 32)  
_____________________________________________________________________ 
      
Patient Sample 




Male (%)    25 (78.1%)   
     




Caucasian (%)     3 (9.4%)   
 
African American (%)  28 (87.5%)    
 
Asian (%)      1 (3.1%) 
 
Hispanic (%)      0 (0.0%)    
 




Attended some high school (%) 13 (40.6%)    
  
High School Graduate (%)  12 (37.5%)    
 




Employed (%)    10 (31.3%) 
 
Unemployed (%)   22 (68.8%) 
 











Intra-class Correlations (ICC) for FACES Variables (N = 32) 
 
     ICC   ICC   
Pair 1  Pair 2   
 
Frequency of positive expressions  .98   .99     
 
Duration of positive expressions  .99   .89    
 
Intensity of positive expressions  .93   .99    
 








































Correlations Between Individual FACES Variables (N = 32) 
  
       r    
 
Frequency x Duration   .59*    
 
Frequency x Intensity   .71*    
  
Duration x Intensity   .78*    
                                                                                                                                                 









































Correlations Between NSRS Subscales and FACES Variables(r) 
 





 Anhedonia (N = 27)       -.16                 .00                 -.08 
  
 Asociality (N = 29)       -.30      -.21                    .00 
  
 Avolition (N = 26)       -.23     -.34                 -.28 
 
 Blunted Affect (N = 32)      -.50**    -.52**     -.42*      
  
 Alogia (N = 32)       -.22     -.28                 -.04 
 
































Correlations between FACES Subscales and Psychotic and Depressive 
Symptomatology 
 
BPRS Thought  Calgary Depression 





 Frequency                             -.09                          -.16  
        
 
 Intensity                                      .12             -.21 
 
 Duration          .14            -.23 
 



































Correlations Between Social Functioning Scale Variables and FACES Variables(r) 
 




Engagement/Withdrawal (N = 30)          .01     .08      .02 
  
 
Interpersonal Behavior (N = 28)      .31     .33      .24 
  
Pro-Social Behavior (N = 31)       .12     .03      .08  
 
Recreation (N = 31)       -.07    -.15     -.15 
 
Independence/Competence (N = 29)     -.28    -.39     -.36 
  
Independence/Performance (N = 24)      .03    -.04      .04 
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